Elevated nucleosome levels in systemic inflammation and sepsis

Critical Care Medicine

Volumn 31, Issue 7, 2003, Pages 1947-1951

  Zeerleder, Sacha ^a,b   Zwart, Bas ^b   Wuillemin, Walter A ^c   Aarden, Lucien A ^b   Groeneveld, A B Johan ^d   Caliezi, Christoph ^a   Van Nieuwenhuijze, Annemarie E M ^b   Van Mierlo, Gerard J ^b   Eerenberg, Anke J M ^b   Lämmle, Bernhard ^a   Hack, C Erik ^b,d  

^a UNIVERSITY OF BERN   (Switzerland)

^b CENTRAL LABORATORY   (Netherlands)

^c LUZERNER KANTONSSPITAL   (Switzerland)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Multiple organ dysfunction syndrome; Nucleosome; Sepsis

Indexed keywords

CYTOKINE;

ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; NUCLEOSOME; PREDICTION; PRIORITY JOURNAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 0041849685     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000074719.40109.95     Document Type: Article

References (29)

1. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 1995; 273:117-123
2. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation. Crit Care Med 1996; 24:163-172
3. Papathanassoglou EDE, Moynihan JA, Ackerman MH: Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and theoretical framework. Crit Care Med 2000; 28:537-549
4. Hotchkiss RS, Swanson PE, Cobb JP, et al: Apoptosis in lymphoid and parenchymal cells during sepsis: Findings in normal and T- and B-cell-deficient mice. Crit Care Med 1997; 25:1298-1307
5. Leist M, Gantner F, Bohlinger I, et al: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146:1220-1234
6. Endo S, Inada K, Takakuwa T, et al: Nitrite/nitrate (NOx) and sFas antigen levels in patients with multiple organ failure. Res Commun Mol Pathol Pharmacol 1996; 92:253-256
7. Yamada Y, Endo S, Kasai T, et al: Nuclear matrix protein, tumor necrosis factor-alpha, and nitrite/nitrate levels in patients with multiple organ dysfunction syndrome. Res Commun Mol Pathol Pharmacol 1998; 100:92-104
8. Coutinho HB, Robalinho TI, Coutinho VB, et al: Intra-abdominal sepsis: An immunocyto-chemical study of the small intestine mucosa. J Clin Pathol 1997; 50:294-298
9. Earnshaw WC: Nuclear changes in apoptosis. Curr Opin Cell Biol 1995; 7:337-343
10. Amoura Z, Pierre JC, Bach JF, et al: The key role of nucleosomes in lupus. Arthritis Rheum 1999; 42:833-843
11. Holdenrieder S, Stieber P, Bodenmuller H, et al: Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med 2001; 39:596-605
12. Kuroi K, Tanaka C, Toi M: Clinical significance of plasma nucleosome levels in cancer patients. Int J Oncol 2001; 19:143-148
13. Bossink AWJ, Groeneveld ABJ, Hack CE, et al: The clinical host response to microbial infection in medical patients with fever. Chest 1999; 116:380-390
14. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
15. Ziegler EJ, Fisher CF Jr, Sprung CL, et al: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 1991; 324:429-436
16. LeGall JR, Klar J, Lemeshow S, et al: The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. JAMA 1996; 276:802-810
17. Vincent JL, Moreno R, Takala J, et al: The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710
18. Caliezi C, Zeerleder S, Redondo M, et al: C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction. Crit Care Med 2002; 30:1722-1728
19. Helle M, Boeije L, de Groot E, et al: Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: Synovial fluids and sera. J Immunol Methods 1991; 138:47-56
20. Jansen PM, Eisele B, de Jong IW, et al: Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. J Immunol 1998; 160:475-484
21. Schultz MJ, Speelman P, Hack CE, et al: Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae. J Antimicrob Chemother 2000; 46:235-240
22. van Lopik T, Bijl M, Hart M, et al: Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapse. J Rheumatol 1999; 26:60-67
23. Portielje JEA, Kruit WHJ, Eerenberg MM, et al: Interleukin 12 induces activation of fibrinolysis and coagulation in humans. Br J Haematol 2001; 112:499-505
24. Mallat Z, Tedgui A: Apoptosis in the vasculature: Mechanisms and functional importance. Br J Pharmacol 2000; 130:947-962
25. Licht R, van Bruggen MC, Oppers-Walgreen B, et al: Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: Effects of disease progression and lipopolysaccharide administration. Arthritis Rheum 2001; 44:1320-1330
26. Bazzoni F, Beutler B: The tumor necrosis factor ligand and receptor families. N Engl J Med 1996; 334:1717-1725
27. Kohli V, Selzner M, Madden JF, et al: Endothelial cell and hepatocyte death occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999; 67:1099-1105
28. Gua RF, Huber-Lang M, Wang X, et al: Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J Clin Invest 2000; 106:1271-1280
29. Stefanec T: Endothelial apoptosis: Could it have a role in the pathogenesis and treatment of disease. Chest 2000; 117:841-854